-IPS News THIRUVANANTHAPURAM: Balakrishnan, a labourer from Kochi in the southern Indian state of Kerala, was suffering from oral cancer. He was admitted to the Regional Cancer Centre (RCC) in Thiruvananthapuram. After the first course of radiation therapy, the 60-year-old could not eat or drink because of severe pain and infection in the mouth. An Ayurvedic mouth wash developed from the Neem plant was administered to Balakrishnan for three weeks during the...

-Frontline In a situation of increasing life expectancy and crumbling traditional support structures, a universal social pension scheme that does not rely on contribution by a person or an employer can help the elderly. INDIA prides itself on being a "young" society, likely to benefit from a demographic dividend as children and young people move into working age groups over the next decade. This optimistic view assumes that society will be able...

-The Economic Times Anshu Prakash is worried about what he calls "mischievous propaganda" by "some people" who he thinks are misleading reporters. The joint secretary at the ministry of health and family welfare starts off by flatly denying that the joint monitoring mission (JMM) set up by the World Health Organization (WHO) and the government of India (GoI) discussed the impending danger of a TB drugs stock-out in August 2012. "There was...

-The Hindu New Delhi: Doctors of ayurveda and three other systems of medicine may be legally permitted to prescribe modern medicine under a controversial proposal from the Union health ministry that has angered sections of modern medics. The health ministry has asked state governments to take steps to allow state medical councils to enrol doctors with degrees in the traditional systems of medicine - ayurveda, unani, siddha, and homeopathy (AYUSH) - to...

-The Times of India Big pharma may be crying hoarse over India's "weak'' intellectual property environment, but over the past five years or so, they have introduced only a handful of their patented blockbusters in the country. That's not all. The contribution of patented drugs in the Rs 72,000-crore pharma retail market is not even 1%, indicating that multinationals have been traditionally slow and have a poor track record in introducing...